3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Urogenital Neoplasms
1
Ovarian Neoplasms
1
Ovarian Diseases
1
Ovarian Cysts
1
Neoplasms
1
Gonadal Disorders
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Endocrine System Diseases
1
Endocrine Gland Neoplasms
1
Disease
1
Cysts
1
Adnexal Diseases
1
Interventions
Bevacizumab
2
temsirolimus
1
niraparib
1
lutetium Lu 177 dotatate
1
copper dotatate CU-64
1
Valproic Acid
1
Therapeutic Irrigation
1
Sunitinib
1
Staining and Labeling
1
Sirolimus
1
Psilocybin
1
Phlebotomy
1
Lutetium-177
1
Lutetium
1
Irinotecan
1
Immunoglobulin G
1
Gemcitabine
1
Etoposide
1
Disulfides
1
Diffusion
1
Cyclophosphamide
1
Cisplatin
1
Cetuximab
1
Capecitabine
1
Blood Specimen Collection
1
Biopsy, Large-Core Needle
1
Ascorbic Acid
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Endocrine Gland Neoplasms
×
Diffusion
×
Clear all
NCT02836275
2020-04-14
IOTA-MRI
KU Leuven
Phase NA
Unknown
250 enrolled